Meet the JCC Plus authors: Thea H. Wiken & Karoline Anisdahl
Written by
Arianna Dal Buono
ECCO News Associate Editor
Dear ECCO Friends and Family,
In this episode of ECCO News “Meet the JCC Plus Authors”, we speak with Dr. Thea Helm Wiken and Dr. Karoline Anisdahl about their recent study comparing vedolizumab and ustekinumab in TNF inhibitor–experienced ulcerative colitis patients. Drawing on real-world data and a therapeutic drug monitoring approach, the study provides valuable insights into treatment effectiveness, timing of response, and the role of dose optimization in clinical practice.
I hope you enjoy watching the video.
Arianna Dal Buono ECCO News Associate Editor
This is a placeholder for a Vimeo video. By clicking "Accept & load Vimeo" the video will be loaded and data can be transmitted to third parties. Learn more
